Abstract
Background: Unexpected death of a loved one (UD) is the most commonly reported traumatic experience in cross-national surveys. However, much remains to be learned about posttraumatic stress disorder (PTSD) after this experience. The WHO World Mental Health (WMH) survey initiative provides a unique opportunity to address these issues. Methods: Data from 19 WMH surveys (n = 78,023; 70.1% weighted response rate) were collated. Potential predictors of PTSD (respondent sociodemographics, characteristics of the death, history of prior trauma exposure, history of prior mental disorders) after a representative sample of UDs were examined using logistic regression. Simulation was used to estimate overall model strength in targeting individuals at highest PTSD risk. Results: PTSD prevalence after UD averaged 5.2% across surveys and did not differ significantly between high-income and low-middle income countries. Significant multivariate predictors included the deceased being a spouse or child, the respondent being female and believing they could have done something to prevent the death, prior trauma exposure, and history of prior mental disorders. The final model was strongly predictive of PTSD, with the 5% of respondents having highest estimated risk including 30.6% of all cases of PTSD. Positive predictive value (i.e., the proportion of high-risk individuals who actually developed PTSD) among the 5% of respondents with highest predicted risk was 25.3%. Conclusions: The high prevalence and meaningful risk of PTSD make UD a major public health issue. This study provides novel insights into predictors of PTSD after this experience and suggests that screening assessments might be useful in identifying high-risk individuals for preventive interventions.
Original language | English |
---|---|
Pages (from-to) | 315-326 |
Number of pages | 12 |
Journal | Depression and Anxiety |
Volume | 34 |
Issue number | 4 |
DOIs | |
Publication status | Published - 1 Apr 2017 |
Externally published | Yes |
Keywords
- PTSD
- cross-national
- epidemiology
- international
- life events/stress
- trauma
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Posttraumatic stress disorder associated with unexpected death of a loved one: Cross-national findings from the world mental health surveys'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Depression and Anxiety, Vol. 34, No. 4, 01.04.2017, p. 315-326.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Posttraumatic stress disorder associated with unexpected death of a loved one
T2 - Cross-national findings from the world mental health surveys
AU - on behalf of the WHO World Mental Health Survey Collaborators
AU - Atwoli, Lukoye
AU - Stein, Dan J.
AU - King, Andrew
AU - Petukhova, Maria
AU - Aguilar-Gaxiola, Sergio
AU - Alonso, Jordi
AU - Bromet, Evelyn J.
AU - de Girolamo, Giovanni
AU - Demyttenaere, Koen
AU - Florescu, Silvia
AU - Maria Haro, Josep
AU - Karam, Elie G.
AU - Kawakami, Norito
AU - Lee, Sing
AU - Lepine, Jean Pierre
AU - Navarro-Mateu, Fernando
AU - O'Neill, Siobhan
AU - Pennell, Beth Ellen
AU - Piazza, Marina
AU - Posada-Villa, Jose
AU - Sampson, Nancy A.
AU - ten Have, Margreet
AU - Zaslavsky, Alan M.
AU - Kessler, Ronald C.
N1 - Funding Information: The World Health Organization World Mental Health Survey collaborators are Tomasz Adamowski, Ph.D., M.D., Sergio Aguilar-Gaxiola, M.D., Ph.D., Ali Al-Hamzawi, M.D., Mohammad Al-Kaisy, M.D., Abdullah Al Subaie, M.B.B.S., FRCP, Jordi Alonso, M.D., Ph.D., Yasmin Altwaijri, M.S., Ph.D., Laura Helena Andrade, M.D., Ph.D., Lukoye Atwoli, M.D., Ph.D., Randy P. Auerbach, Ph.D., William G. Axinn, Ph.D., Corina Benjet, Ph.D., Guilherme Borges, Sc.D., Robert M. Bossarte, Ph.D., Evelyn J. Bromet, Ph.D., Ronny Bruffaerts, Ph.D., Brendan Bunting, Ph.D., Ernesto Caffo, M.D., Jose Miguel Caldas de Almeida, M.D., Ph.D., Graca Cardoso, M.D., Ph.D., Alfredo H. Cia, M.D., Stephanie Chardoul, Somnath Chatterji, M.D., Alexandre Chiavegatto Filho, Ph.D., Pim Cuijpers, Ph.D., Louisa Degenhardt, Ph.D., Giovanni de Girolamo, M.D., Ron de Graaf, M.S., Ph.D., Peter de Jonge, Ph.D., Koen Demyttenaere, M.D., Ph.D., David D. Ebert, Ph.D., Sara Evans-Lacko, Ph.D., John Fayyad, M.D., Fabian Fiestas, M.D., Ph.D., Silvia Florescu, M.D., Ph.D., Barbara Forresi, Ph.D., Sandro Galea, Dr.P.H., M.D., M.P.H., Laura Germine, Ph.D., Stephen E. Gilman, Sc.D., Dirgha J. Ghimire, Ph.D., Meyer D. Glantz, Ph.D., Oye Gureje, Ph.D., D.Sc., FRCPsych, Josep Maria Haro, M.D., M.P.H., Ph.D., Yanling He, M.D., Hristo Hinkov, M.D., Chi-yi Hu, Ph.D., M.D., Yueqin Huang, M.D., M.P.H., Ph.D., Aimee Nasser Karam, Ph.D., Elie G. Karam, M.D., Norito Kawakami, M.D., D.M.Sc., Ronald C. Kessler, Ph.D., Andrzej Kiejna, M.D., Ph.D., Karestan C. Koenen, Ph.D., Viviane Kovess-Masfety, M.Sc., M.D., Ph.D., Carmen Lara, M.D., Ph.D., Sing Lee, Ph.D., Jean-Pierre Lepine, M.D., Itzhak Levav, M.D., Daphna Levinson, Ph.D., Zhaorui Liu, M.D., M.P.H., Silvia S. Martins, M.D., Ph.D., Herbert Matschinger, Ph.D., John J. McGrath, Ph.D., Katie A. McLaughlin, Ph.D., Maria Elena Medina-Mora, Ph.D., Zeina Mneimneh, Ph.D., M.P.H., Jacek Moskalewicz, Dr.P.H., Samuel D. Murphy, Dr.P.H., Fernando Navarro-Mateu, M.D., Ph.D., Matthew K. Nock, Ph.D., Siobhan O'Neill, Ph.D., Mark Oakley-Browne, M.B., Ch.B., Ph.D., J. Hans Ormel, Ph.D., Beth-Ellen Pennell, M.A., Marina Piazza, M.P.H., Sc.D., Stephanie Pinder-Amaker, Ph.D., Patryk Piotrowski, M.D., Ph.D., Jose Posada-Villa, M.D., Ayelet M. Ruscio, Ph.D., Kate M. Scott, Ph.D., Vicki Shahly, Ph.D., Tim Slade, Ph.D., Jordan W. Smoller, Sc.D., M.D., Juan Carlos Stagnaro, M.D., Ph.D., Dan J. Stein, M.B.A., M.Sc., Ph.D., Amy E. Street, Ph.D., Hisateru Tachimori, Ph.D., Nezar Taib, M.S., Margreet ten Have, Ph.D., Graham Thornicroft, Ph.D., Yolanda Torres, M.P.H., Maria Carmen Viana, M.D., Ph.D., Gemma Vilagut, M.S., Elisabeth Wells, Ph.D., Harvey Whiteford, Ph.D., David R. Williams, M.P.H., Ph.D., Michelle A. Williams, Sc.D., Bogdan Wojtyniak, Sc.D., and Alan M. Zaslavsky, Ph.D. Dr. Stein has received research grants and/or consultancy honoraria from Abbott, AstraZeneca, Eli-Lilly, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, Lundbeck, Orion, Pfizer, Pharmacia, Roche, Servier, Solvay, Sumitomo, Sun, Takeda, Tikvah, and Wyeth. Dr. Demyttenaere has served as a consultant with Servier, Lundbeck, Lundbeck Institute, AstraZeneca, and Naurex. In the past 3 years, Dr. Kessler received support for his epidemiological studies from Sanofi Aventis, was a consultant for Johnson & Johnson Wellness and Prevention, and served on an advisory board for the Johnson & Johnson Services, Inc. Lake Nona Life Project. Dr. Kessler is a coowner of DataStat, Inc., a market research firm that carries out healthcare research. The other authors report no biomedical financial interests or potential conflicts of interest relevant to this manuscript. The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the National Institute of Mental Health (NIMH; R01 MH070884 and R01 MH093612-01), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the US Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical, Inc., GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. The São Paulo Megacity Mental Health Survey is supported by the State of São Paulo Research Foundation (FAPESP) Thematic Project grant 03/00204-3. The Bulgarian Epidemiological Study of common mental disorders EPIBUL is supported by the Ministry of Health and the National Center for Public Health Protection. The Colombian National Study of Mental Health (NSMH) is supported by the Ministry of Social Protection. The Mental Health Study Medellín—Colombia was carried out and supported jointly by the Center for Excellence on Research in Mental Health (CES University) and the Secretary of Health of Medellín. The ESEMeD project is funded by the European Commission (contracts QLG5-1999-01042; SANCO 2004123, and EAHC 20081308; the Piedmont Region [Italy]), Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Spain (FIS 00/0028), Ministerio de Ciencia y Tecnología, Spain (SAF 2000-158-CE), Departament de Salut, Generalitat de Catalunya, Spain, Instituto de Salud Carlos III (CIBER CB06/02/0046, RETICS RD06/0011 REM-TAP), and other local agencies and by an unrestricted educational grant from GlaxoSmithKline. The World Mental Health Japan (WMHJ) survey is supported by the Grant for Research on Psychiatric and Neurological Diseases and Mental Health (H13-SHOGAI-023, H14-TOKUBETSU-026, H16-KOKORO-013) from the Japan Ministry of Health, Labour and Welfare. The Lebanese Evaluation of the Burden of Ailments and Needs of the Nation (L.E.B.A.N.O.N.) is supported by the Lebanese Ministry of Public Health, the WHO (Lebanon), National Institute of Health/Fogarty International Center (R03 TW006481-01), anonymous private donations to IDRAAC, Lebanon, and unrestricted grants from Algorithm, AstraZeneca, Benta, Bella Pharma, Eli Lilly, Glaxo Smith Kline, Lundbeck, Novartis, Servier, Phenicia, UPO. The Northern Ireland Study of Mental Health was funded by the Health & Social Care Research & Development Division of the Public Health Agency. The Peruvian World Mental Health Study was funded by the National Institute of Health of the Ministry of Health of Peru. The Romania WMH study projects “Policies in Mental Health Area” and “National Study regarding Mental Health and Services Use” were carried out by National School of Public Health & Health Services Management (former National Institute for Research & Development in Health), with technical support of Metro Media Transilvania, the National Institute of Statistics—National Centre for Training in Statistics, SC, Cheyenne Services SRL, Statistics Netherlands, and were funded by Ministry of Public Health (former Ministry of Health) with supplemental support of Eli Lilly Romania SRL. The South Africa Stress and Health Study (SASH) is supported by the US National Institute of Mental Health (R01-MH059575) and National Institute of Drug Abuse with supplemental funding from the South African Department of Health and the University of Michigan. Dr. Stein is supported by the Medical Research Council of South Africa (MRC). The Psychiatric Enquiry to General Population in Southeast Spain—Murcia (PEGASUS-Murcia) Project has been financed by the Regional Health Authorities of Murcia (Servicio Murciano de Salud and Consejería de Sanidad y Política Social) and Fundación para la Formación e Investigación Sanitarias (FFIS) of Murcia. The Ukraine Comorbid Mental Disorders during Periods of Social Disruption (CMDPSD) study is funded by the US National Institute of Mental Health (RO1-MH61905). The US National Comorbidity Survey Replication (NCS-R) is supported by the National Institute of Mental Health (NIMH; U01-MH60220) with supplemental support from the National Institute of Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), the Robert Wood Johnson Foundation (RWJF; grant 044708), and the John W. Alden Trust. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the sponsoring organizations, agencies, or governments. A complete list of all within-country and cross-national WMH publications can be found at http://www.hcp.med.harvard.edu/wmh/. Publisher Copyright: © 2016 Wiley Periodicals, Inc.
PY - 2017/4/1
Y1 - 2017/4/1
N2 - Background: Unexpected death of a loved one (UD) is the most commonly reported traumatic experience in cross-national surveys. However, much remains to be learned about posttraumatic stress disorder (PTSD) after this experience. The WHO World Mental Health (WMH) survey initiative provides a unique opportunity to address these issues. Methods: Data from 19 WMH surveys (n = 78,023; 70.1% weighted response rate) were collated. Potential predictors of PTSD (respondent sociodemographics, characteristics of the death, history of prior trauma exposure, history of prior mental disorders) after a representative sample of UDs were examined using logistic regression. Simulation was used to estimate overall model strength in targeting individuals at highest PTSD risk. Results: PTSD prevalence after UD averaged 5.2% across surveys and did not differ significantly between high-income and low-middle income countries. Significant multivariate predictors included the deceased being a spouse or child, the respondent being female and believing they could have done something to prevent the death, prior trauma exposure, and history of prior mental disorders. The final model was strongly predictive of PTSD, with the 5% of respondents having highest estimated risk including 30.6% of all cases of PTSD. Positive predictive value (i.e., the proportion of high-risk individuals who actually developed PTSD) among the 5% of respondents with highest predicted risk was 25.3%. Conclusions: The high prevalence and meaningful risk of PTSD make UD a major public health issue. This study provides novel insights into predictors of PTSD after this experience and suggests that screening assessments might be useful in identifying high-risk individuals for preventive interventions.
AB - Background: Unexpected death of a loved one (UD) is the most commonly reported traumatic experience in cross-national surveys. However, much remains to be learned about posttraumatic stress disorder (PTSD) after this experience. The WHO World Mental Health (WMH) survey initiative provides a unique opportunity to address these issues. Methods: Data from 19 WMH surveys (n = 78,023; 70.1% weighted response rate) were collated. Potential predictors of PTSD (respondent sociodemographics, characteristics of the death, history of prior trauma exposure, history of prior mental disorders) after a representative sample of UDs were examined using logistic regression. Simulation was used to estimate overall model strength in targeting individuals at highest PTSD risk. Results: PTSD prevalence after UD averaged 5.2% across surveys and did not differ significantly between high-income and low-middle income countries. Significant multivariate predictors included the deceased being a spouse or child, the respondent being female and believing they could have done something to prevent the death, prior trauma exposure, and history of prior mental disorders. The final model was strongly predictive of PTSD, with the 5% of respondents having highest estimated risk including 30.6% of all cases of PTSD. Positive predictive value (i.e., the proportion of high-risk individuals who actually developed PTSD) among the 5% of respondents with highest predicted risk was 25.3%. Conclusions: The high prevalence and meaningful risk of PTSD make UD a major public health issue. This study provides novel insights into predictors of PTSD after this experience and suggests that screening assessments might be useful in identifying high-risk individuals for preventive interventions.
KW - PTSD
KW - cross-national
KW - epidemiology
KW - international
KW - life events/stress
KW - trauma
UR - http://www.scopus.com/inward/record.url?scp=85006489764&partnerID=8YFLogxK
U2 - 10.1002/da.22579
DO - 10.1002/da.22579
M3 - Article
C2 - 27921352
AN - SCOPUS:85006489764
SN - 1091-4269
VL - 34
SP - 315
EP - 326
JO - Depression and Anxiety
JF - Depression and Anxiety
IS - 4
ER -